Index S&P 500
P/E 25.39
EPS (ttm) 3.62
Insider Own 0.07%
Shs Outstand 1.28B
Perf Week 1.39%
Market Cap 117.96B
Forward P/E 15.13
EPS next Y 6.08
Insider Trans -0.40%
Shs Float 1.28B
Perf Month -4.70%
Enterprise Value 138.68B
PEG 4.30
EPS next Q 1.31
Inst Own 86.99%
Short Float 1.17%
Perf Quarter -0.84%
Income 4.66B
P/S 3.45
EPS this Y 2.46%
Inst Trans -0.64%
Short Ratio 2.15
Perf Half Y 10.16%
Sales 34.20B
P/B 2.46
EPS next Y 8.02%
ROA 5.16%
Short Interest 14.95M
Perf YTD 15.12%
Book/sh 37.36
P/C 14.52
EPS next 5Y 5.90%
ROE 9.72%
52W High 99.37 -7.46%
Perf Year 2.54%
Cash/sh 6.33
P/FCF 22.24
EPS past 3/5Y -1.03% 0.39%
ROIC 6.29%
52W Low 79.29 15.98%
Perf 3Y 7.20%
Dividend Est. 2.85 (3.10%)
EV/EBITDA 14.97
Sales past 3/5Y 1.91% 3.01%
Gross Margin 59.81%
Volatility 1.34% 1.70%
Perf 5Y -10.22%
Dividend TTM 2.82 (3.07%)
EV/Sales 4.06
EPS Y/Y TTM 22.08%
Oper. Margin 18.47%
ATR (14) 1.61
Perf 10Y 24.40%
Dividend Ex-Date Sep 26, 2025
Quick Ratio 1.50
Sales Y/Y TTM 4.98%
Profit Margin 13.63%
RSI (14) 43.63
Recom 2.15
Dividend Gr. 3/5Y 3.57% 5.33%
Current Ratio 2.01
EPS Q/Q 0.54%
SMA20 -1.52%
Beta 0.73
Target Price 100.93
Payout 77.47%
Debt/Eq 0.60
Sales Q/Q 8.38%
SMA50 -2.38%
Rel Volume 0.62
Prev Close 90.06
Employees 95000
LT Debt/Eq 0.55
Earnings Nov 18 BMO
SMA200 2.32%
Avg Volume 6.95M
Price 91.96
IPO Nov 21, 1977
Option/Short Yes / Yes
EPS/Sales Surpr. 2.53% 2.38%
Trades
Volume 3,806,244
Change 2.11%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-30-25 Upgrade
Wolfe Research
Underperform → Peer Perform
Jun-16-25 Initiated
Leerink Partners
Outperform
$110
Mar-04-25 Upgrade
Citigroup
Neutral → Buy
$92 → $107
Oct-10-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$98 → $105
Aug-21-24 Reiterated
Oppenheimer
Perform
$92 → $94
Aug-15-24 Upgrade
UBS
Sell → Neutral
$76 → $90
Aug-14-24 Downgrade
Stifel
Buy → Hold
$100 → $85
May-30-24 Initiated
Goldman
Sell
$83
Jul-19-23 Initiated
Robert W. Baird
Neutral
$90
Jun-30-23 Initiated
CL King
Buy
$106
May-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$104
Apr-24-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$77 → $100
Mar-29-23 Downgrade
UBS
Buy → Sell
$127 → $79
Jan-09-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$102 → $89
Nov-23-22 Downgrade
Oppenheimer
Outperform → Perform
$106 → $85
Nov-23-22 Downgrade
Citigroup
Buy → Neutral
$108 → $85
Nov-16-22 Downgrade
Deutsche Bank
Buy → Hold
$85
Oct-18-22 Initiated
Barclays
Equal Weight
$90
Oct-13-22 Initiated
Mizuho
Buy
$100
Oct-12-22 Initiated
Jefferies
Hold
$87
Show Previous Ratings
Today 06:40AM
Nov-05-25 05:43PM
05:20PM
09:20AM
05:10AM
06:45AM
Loading…
Nov-04-25 06:45AM
05:15AM
Oct-30-25 08:38AM
Oct-29-25 05:50PM
07:12AM
Oct-28-25 06:36PM
06:49AM
Oct-27-25 11:14AM
08:40AM
08:00AM
05:24PM
Loading…
Oct-26-25 05:24PM
04:39AM
04:00AM
Oct-23-25 05:50PM
03:43AM
Oct-20-25 09:32AM
08:45AM
06:30AM
Oct-16-25 01:02PM
07:26AM
04:25AM
01:55AM
Oct-15-25 05:50PM
12:20PM
09:50AM
08:05AM
Loading…
08:05AM
Oct-14-25 09:40AM
08:35AM
Oct-13-25 07:15PM
08:20AM
Oct-09-25 05:50PM
10:10AM
Oct-08-25 07:00AM
Oct-04-25 08:01AM
Oct-03-25 05:50PM
05:54AM
Oct-02-25 08:00AM
07:06AM
04:37AM
Oct-01-25 10:13AM
Sep-29-25 01:26PM
09:50AM
08:09AM
Sep-26-25 11:57AM
11:30AM
Sep-25-25 05:50PM
11:16AM
09:40AM
07:20AM
05:40AM
Sep-24-25 11:24AM
08:56AM
08:49AM
07:24AM
Sep-22-25 06:00AM
05:54AM
Sep-19-25 11:10AM
08:00AM
Sep-18-25 11:30AM
07:13AM
Sep-17-25 09:45AM
Sep-15-25 05:41PM
09:01AM
09:00AM
Sep-14-25 02:03PM
Sep-13-25 05:54AM
Sep-11-25 07:57AM
06:30AM
Sep-10-25 08:56AM
07:20AM
06:20AM
04:53AM
Sep-05-25 09:45AM
08:50AM
06:05AM
06:00AM
Sep-04-25 02:20PM
12:15PM
06:00AM
Sep-03-25 08:49AM
05:55AM
02:55AM
Sep-02-25 11:13AM
11:06AM
08:45AM
Sep-01-25 12:11PM
Aug-30-25 04:05AM
Aug-29-25 11:22AM
07:00AM
Aug-28-25 03:17PM
08:48AM
Aug-26-25 09:50AM
Aug-25-25 05:41PM
05:00AM
04:04AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KIIL HARRY SKIP EVP & President Cardiovascular Sep 03 '25 Sale 91.58 8,605 788,048 35,615 Sep 05 04:18 PM KIIL HARRY SKIP Officer Sep 03 '25 Proposed Sale 91.58 8,605 788,049 Sep 03 03:23 PM Jellison William R Director Aug 22 '25 Buy 92.73 2,500 231,825 2,500 Aug 25 05:18 PM Jellison William R Director Aug 25 '25 Buy 92.37 2,500 230,925 5,000 Aug 25 05:18 PM Walter Matthew R. SVP, Chief HR Officer Aug 01 '25 Option Exercise 23.91 3,142 75,114 32,804 Aug 04 04:21 PM Wall Brett A. EVP & Pres Neuroscience Aug 01 '25 Option Exercise 0.00 15,249 0 66,531 Aug 04 04:20 PM Smith Gregory L EVP Global Ops & Supply Chain Aug 01 '25 Option Exercise 0.00 11,328 0 83,071 Aug 04 04:19 PM Martha Geoffrey Chairman and CEO Aug 01 '25 Option Exercise 32.21 98,324 3,166,800 284,923 Aug 04 04:18 PM Marinaro Michael EVP, Pres MedSurg and Americas Aug 01 '25 Option Exercise 25.24 9,661 243,828 57,628 Aug 04 04:17 PM KIIL HARRY SKIP EVP & President Cardiovascular Aug 01 '25 Option Exercise 0.00 10,457 0 51,775 Aug 04 04:16 PM Blomquist Denise L. Chief Accounting Officer Aug 01 '25 Option Exercise 32.22 518 16,692 12,671 Aug 04 04:15 PM Salmon Sean Officer Jun 06 '25 Proposed Sale 86.81 18,378 1,595,469 Jun 06 02:43 PM Walter Matthew R. SVP, Chief HR Officer Jan 27 '25 Option Exercise 74.84 1,337 100,061 26,997 Jan 28 05:10 PM Marinaro Michael EVP & President, Surgical OU Jan 27 '25 Option Exercise 74.84 2,345 175,500 43,323 Jan 28 05:09 PM Martha Geoffrey Chairman and CEO Jan 27 '25 Option Exercise 74.84 34,741 2,600,016 216,954 Jan 28 05:07 PM Wall Brett A. EVP & Pres Neuroscience Jan 24 '25 Option Exercise 78.00 12,437 970,086 53,416 Jan 27 05:35 PM Wall Brett A. EVP & Pres Neuroscience Jan 24 '25 Sale 90.00 12,437 1,119,330 40,979 Jan 27 05:35 PM Wall Brett A. Officer Jan 24 '25 Proposed Sale 90.00 12,437 1,119,330 Jan 24 02:34 PM Wall Brett A. EVP & Pres Neuroscience Jan 08 '25 Option Exercise 74.84 6,850 512,654 50,558 Jan 10 04:48 PM Wall Brett A. EVP & Pres Neuroscience Jan 08 '25 Sale 80.41 9,850 792,038 40,708 Jan 10 04:48 PM Wall Brett A. Officer Jan 08 '25 Proposed Sale 80.41 9,850 792,038 Jan 08 09:52 AM